A simple protective antigen (PA)-reactive mAb dot-ELISA was standardized for confirmation of toxin-producing strains of Bacillus anthracis. Twenty-seven clinical isolates were collected from patients clinically suspected of having anthrax. PA was elaborated from these isolates using Casamino acids medium and the culture medium was boiled to kill the cells. PA in boiled culture supernatants was detected using a dot-ELISA. Of the 27 clinical isolates tested, PA was detected in 24 isolates. This was further confirmed by amplifying the PA gene by PCR. This testing procedure is simple to perform, specific and safer than existing procedures, which are added advantages over existing methods of identification of B. anthracis. This test system could...
A mass-screening protocol for the diagnosis of anthrax from nasal swabs based on an enrichment step ...
Several studies have demonstrated that the passive transfer of protective antigen (PA)-neutralizing ...
A two-component direct fluorescent-antibody (DFA) assay, using fluorescein-labeled monoclonal antibo...
Protective antigen (PA) plays crucial roles in the pathogenicity and virulence of Bacillus anthracis...
this disease. There is considerable under reporting of the disease because of lack of microbiologica...
The bioterrorism-associated human anthrax epidemic in the fall of 2001 highlighted the need for a se...
Protective antigen, isolated by gel chromatography with the help of sephacril S-300 from the cultura...
The bioterrorism-associated human anthrax epidemic in the fall of 2001 highlighted the need for a se...
ABSTRACTThree extractable Bacillus anthracis cell-wall-associated antigens were evaluated for potent...
During the outbreak of anthrax, early diagnosis is critical for effective treatment. Numerous attemp...
Existing research for using the protective antigen (PA) of Bacillus anthracis as a vaccine component...
Anthrax caused by Bacillus anthracis is a public health problem in several developing countries whos...
Bacillus anthracis, the causative agent of anthrax disease, could be used as a biothreat reagent. It...
The protective antigen (PA) component of the anthrax toxins is an essential virulence factor of Baci...
responses were studied in patients with bioterrorism-related cutaneous or inhalation anthrax and in ...
A mass-screening protocol for the diagnosis of anthrax from nasal swabs based on an enrichment step ...
Several studies have demonstrated that the passive transfer of protective antigen (PA)-neutralizing ...
A two-component direct fluorescent-antibody (DFA) assay, using fluorescein-labeled monoclonal antibo...
Protective antigen (PA) plays crucial roles in the pathogenicity and virulence of Bacillus anthracis...
this disease. There is considerable under reporting of the disease because of lack of microbiologica...
The bioterrorism-associated human anthrax epidemic in the fall of 2001 highlighted the need for a se...
Protective antigen, isolated by gel chromatography with the help of sephacril S-300 from the cultura...
The bioterrorism-associated human anthrax epidemic in the fall of 2001 highlighted the need for a se...
ABSTRACTThree extractable Bacillus anthracis cell-wall-associated antigens were evaluated for potent...
During the outbreak of anthrax, early diagnosis is critical for effective treatment. Numerous attemp...
Existing research for using the protective antigen (PA) of Bacillus anthracis as a vaccine component...
Anthrax caused by Bacillus anthracis is a public health problem in several developing countries whos...
Bacillus anthracis, the causative agent of anthrax disease, could be used as a biothreat reagent. It...
The protective antigen (PA) component of the anthrax toxins is an essential virulence factor of Baci...
responses were studied in patients with bioterrorism-related cutaneous or inhalation anthrax and in ...
A mass-screening protocol for the diagnosis of anthrax from nasal swabs based on an enrichment step ...
Several studies have demonstrated that the passive transfer of protective antigen (PA)-neutralizing ...
A two-component direct fluorescent-antibody (DFA) assay, using fluorescein-labeled monoclonal antibo...